American journal of infection control · 2026
An evaluation of technical assistance provided to infection prevention and control and antimicrobial resistance programs funded by the Global Fund's COVID-19 Response Mechanism.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nsoh Marius, Leighty Elizabeth, Rigodon Jonas, Kabamba Khen, Kihungi Loyce, Livinus Ibiang, Nandi Sylvester, Tola Kasu, Bailey Claire, Herzig Carolyn, Mann Sean, Soura Biesse, Weiss Jamine, Vasquez Amber, Malpiedi Paul
Аннотация
BACKGROUND: Effective infection prevention and control (IPC) programs are essential for preventing healthcare-associated infections and combating antimicrobial resistance (AR), particularly in low- and middle-income countries (LMICs). The Global Fund's COVID-19 Response Mechanism (C19RM) created an opportunity for countries to receive funding to strengthen IPC and AR programs. In 2022, the United States Centers for Disease Control and Prevention, in partnership with the CDC Foundation, provided technical assistance (TA) to seven countries that received C19RM IPC and AR funds. This manuscript describes an evaluation of the TA program.
METHODS: TA was delivered by in-country consultants and US-based experts via virtual engagement and in-person visits. A mixed-methods evaluation was conducted, analyzing monitoring data, surveys, and key informant interviews. Guided by the CDC Framework for Program Evaluation and an adapted Kirkpatrick Model, the evaluation assessed TA delivery and recipient satisfaction and perceptions of TA.
RESULTS: All 12 survey respondents reported satisfaction, noting that TA increased C19RM funding awareness and supported proposal development, with approximately $14 million in C19RM IPC and AR funds awarded in their countries. Recipients perceived improved capacity to plan, implement, coordinate, and monitor IPC and AR activities.
CONCLUSIONS: These findings highlight the value of tailored TA for IPC and AR programs.
METHODS: TA was delivered by in-country consultants and US-based experts via virtual engagement and in-person visits. A mixed-methods evaluation was conducted, analyzing monitoring data, surveys, and key informant interviews. Guided by the CDC Framework for Program Evaluation and an adapted Kirkpatrick Model, the evaluation assessed TA delivery and recipient satisfaction and perceptions of TA.
RESULTS: All 12 survey respondents reported satisfaction, noting that TA increased C19RM funding awareness and supported proposal development, with approximately $14 million in C19RM IPC and AR funds awarded in their countries. Recipients perceived improved capacity to plan, implement, coordinate, and monitor IPC and AR activities.
CONCLUSIONS: These findings highlight the value of tailored TA for IPC and AR programs.